Live Quote · NASDAQACADHealthcare· Biotechnology

Acadia Pharmaceuticals Inc.

$17.11▼ 2.73%($-0.48)
MKT CAP $2.96BNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
75/100
▌ Solid
73
Valuation
100
Profitability
90
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACAD research report →

Analyst Price Target
$30.05+75.6% vs. today

Range $14.5 – $38

Analyst RatingBuy
25 Buy11 Hold1 Sell

Price Chart

-25.28% · this period
$30.57$23.54$16.50Nov 20May 26Nov 20
52-Week Range8% of range
Low
$15.86
Current
$17.11
High
$30.96